These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32835931)

  • 1. Efficacy of purified fractions of Artemisia ludoviciana Nutt. mexicana and ultraestructural damage to newly excysted juveniles of Fasciola hepatica in vitro.
    Ezeta-Miranda A; Vera-Montenegro Y; Avila-Acevedo JG; García-Bores AM; Estrella-Parra EA; Francisco-Marquez G; Ibarra-Velarde F
    Vet Parasitol; 2020 Sep; 285():109184. PubMed ID: 32835931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the ovicidal activity and fasciolicidal activity of the extract of ethyl acetate from Artemisia ludoviciana Nutt. spp. mexicana and of artemisinin against adult parasites of Fasciola hepatica.
    Ezeta-Miranda A; Avila-Acevedo JG; Vera-Montenegro Y; Francisco-Marquez G
    Parasitol Res; 2023 Dec; 123(1):71. PubMed ID: 38148378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro antihelmintic effect of fifteen tropical plant extracts on excysted flukes of Fasciola hepatica.
    Alvarez-Mercado JM; Ibarra-Velarde F; Alonso-Díaz MÁ; Vera-Montenegro Y; Avila-Acevedo JG; García-Bores AM
    BMC Vet Res; 2015 Feb; 11():45. PubMed ID: 25890066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Abies procera-derived tetracyclic triterpene containing a steroid-like nucleus core and a lactone side chain attenuates in vitro survival of both Fasciola hepatica and Schistosoma mansoni.
    Whiteland HL; Chakroborty A; Forde-Thomas JE; Crusco A; Cookson A; Hollinshead J; Fenn CA; Bartholomew B; Holdsworth PA; Fisher M; Nash RJ; Hoffmann KF
    Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):465-474. PubMed ID: 30399512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface and internal tegumental changes in juvenile Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha.
    McConville M; Brennan GP; Flanagan A; Edgar HW; McCoy M; Castillo R; Hernández-Campos A; Fairweather I
    Vet Parasitol; 2008 May; 153(1-2):52-64. PubMed ID: 18359570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro fasciolicide activity of some plant extracts against newly excysted flukes.
    Vera-Montenegro Y; Ibarra-Velarde F; Ramírez-Avila G; Munguía-Xochihua J
    Ann N Y Acad Sci; 2008 Dec; 1149():180-2. PubMed ID: 19120205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-helminthic activity of Momordica charantia L. against Fasciola hepatica eggs after twelve days of incubation in vitro.
    Pereira CAJ; Oliveira LLS; Coaglio AL; Santos FSO; Cezar RSM; Mendes T; Oliveira FLP; Conzensa G; Lima WS
    Vet Parasitol; 2016 Sep; 228():160-166. PubMed ID: 27692319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triclabendazole-resistant Fasciola hepatica: beta-tubulin and response to in vitro treatment with triclabendazole.
    Robinson MW; Trudgett A; Hoey EM; Fairweather I
    Parasitology; 2002 Mar; 124(Pt 3):325-38. PubMed ID: 11922434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tegumental surface changes in juvenile Fasciola hepatica in response to treatment in vivo with triclabendazole.
    Halferty L; Brennan GP; Hanna RE; Edgar HW; Meaney MM; McConville M; Trudgett A; Hoey L; Fairweather I
    Vet Parasitol; 2008 Aug; 155(1-2):49-58. PubMed ID: 18511199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extraction, fractionation and re-fractionation of Artemisia nilagirica for anticancer activity and HPLC-ESI-QTOF-MS/MS determination.
    Sahu N; Meena S; Shukla V; Chaturvedi P; Kumar B; Datta D; Arya KR
    J Ethnopharmacol; 2018 Mar; 213():72-80. PubMed ID: 29109061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fasciola hepatica: tegumental alterations in adult flukes following in vitro and in vivo administration of artesunate and artemether.
    Keiser J; Morson G
    Exp Parasitol; 2008 Feb; 118(2):228-37. PubMed ID: 17888906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro trematocidal effects of crude alcoholic extracts of Artemisia annua, A. absinthium, Asimina triloba, and Fumaria officinalis: trematocidal plant alcoholic extracts.
    Ferreira JF; Peaden P; Keiser J
    Parasitol Res; 2011 Dec; 109(6):1585-92. PubMed ID: 21562762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotoxicity, acute toxicity and chronic toxicities of ethyl acetate leaf extract of Artemisia ludoviciana Nutt. spp mexicana, on fasciolicidal efficacy.
    Ezeta-Miranda A; Montenegro YV; Ávila Acevedo JG; García Bores AM; Márquez GF
    Exp Parasitol; 2023 Jul; 250():108545. PubMed ID: 37187257
    [No Abstract]   [Full Text] [Related]  

  • 14. Fasciola hepatica: tegumental surface changes in adult and juvenile flukes following treatment in vitro with the sulphoxide metabolite of triclabendazole (Fasinex).
    Stitt AW; Fairweather I
    Parasitol Res; 1993; 79(7):529-36. PubMed ID: 8278333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult triclabendazole-resistant Fasciola hepatica: morphological changes in the tegument and gut following in vivo treatment with artemether in the rat model.
    O'Neill JF; Johnston RC; Halferty L; Brennan GP; Keiser J; Fairweather I
    J Helminthol; 2009 Jun; 83(2):151-63. PubMed ID: 19368748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of the 5-chloro-2-methylthio-6-(1-naphtyloxy)-1H-benzimidazole on the tegument of immature Fasciola hepatica in their natural host.
    Rivera N; Ibarra F; Zepeda A; Fortoul T; Cantó G; Hernández A; Castillo R
    Parasitol Res; 2005 Apr; 95(6):379-82. PubMed ID: 15731908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoglycemic properties of some preparations and compounds from Artemisia ludoviciana Nutt.
    Anaya-Eugenio GD; Rivero-Cruz I; Rivera-Chávez J; Mata R
    J Ethnopharmacol; 2014 Aug; 155(1):416-25. PubMed ID: 24892833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardisation of a coproantigen reduction test (CRT) protocol for the diagnosis of resistance to triclabendazole in Fasciola hepatica.
    Flanagan AM; Edgar HW; Forster F; Gordon A; Hanna RE; McCoy M; Brennan GP; Fairweather I
    Vet Parasitol; 2011 Feb; 176(1):34-42. PubMed ID: 21093156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasciola hepatica: histological changes in the reproductive structures of triclabendazole (TCBZ)-sensitive and TCBZ-resistant flukes after treatment in vivo with TCBZ and the related benzimidazole derivative, Compound Alpha.
    Hanna RE; Edgar HW; McConnell S; Toner E; McConville M; Brennan GP; Devine C; Flanagan A; Halferty L; Meaney M; Shaw L; Moffett D; McCoy M; Fairweather I
    Vet Parasitol; 2010 Mar; 168(3-4):240-54. PubMed ID: 20053501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased action of triclabendazole (TCBZ) in vitro against a TCBZ-resistant isolate of Fasciola hepatica following its co-incubation with the P-glycoprotein inhibitor, R(+)-verapamil.
    Savage J; Meaney M; Brennan GP; Hoey E; Trudgett A; Fairweather I
    Exp Parasitol; 2013 Nov; 135(3):642-53. PubMed ID: 24090567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.